Elucida Oncology, Inc. — Form D/A

Elucida Oncology, Inc. of Monmouth Junction, NJ, a company, filed a Form D amendment with the SEC on 2019-02-07. The offering totals $30.0M, of which $28.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Isaac BlechDirectorJupiter, FL
Robert A EssnerDirectorSarasota, FL
Teresa M ResselDirectorNew York, NY
Robert A RuffoloDirectorNew York, NY
Michael T SmithDirectorArlington, VA
Ulrich T WiesnerDirectorNew York, NY
Michael SmithDirectorAustin, TX
Teresa ResselDirectorPhiladelphia, PA
Robert RuffoloDirectorBoston, MA
Robert EssnerDirectorSarasota, FL
Robert EssnerExecutive OfficerSarasota, FL
Gary SenderDirectorBryan, TX
Tim BorisDirectorRaleigh, NC
David ZacardelliDirectorMonmouth Junction, NJ
Ulrich WiesnerDirectorMonmouth Junction, NJ
Natalie MacDonaldDirectorMonmouth Junction, NJ
Geno GermanoDirectorMonmouth Junction, NJ
Geno GermanoExecutive OfficerMonmouth Junction, NJ
Kai MaExecutive OfficerMonmouth Junction, NJ
Eliel BayeverExecutive OfficerMonmouth Junction, NJ
Somaiya IanExecutive OfficerMonmouth Junction, NJ
Gregory AdamsExecutive OfficerMonmouth Junction, NJ
Tim A BorisDirectorDURHAM, NC
Isaac A BlechDirectorCITY OF INDUSTRY, CA
Steven LarsonDirectorNew York, NY

Other filings by this issuer (11)

FiledFormOfferingSold
2023-08-03D/A$22.3M$22.3M
2023-06-15D$40.0M$22.9M
2022-03-28D$22.3M$22.3M
2021-01-12D/A$35.0M$35.0M
2020-12-29D/A$35.0M$32.6M
2020-12-10D/A$35.0M$27.2M
2020-11-10D$35.0M$17.7M
2020-06-04D/A$30.0M$8.8M
2020-05-26D$30.0M$7.4M
2019-01-03D/A$30.0M$28.1M
2017-08-22D$30.0M$10.9M

More